NL-OMON41680招募中3 期
A randomized controlled trial into the efficacy of neurofeedback for treatment of major depressive disorder - Neurofeedback for depression
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Primary axis-1 disorder of Major Depressive Disorder fulfilling DSM-IV-TR criteria.
- •Written informed consent.
排除标准
- •History of brain trauma (commotio or contusio cerebra) or CVA
- •Current use of antipsychotics, moodstabilizers or benzodiazepines. Current use of antidepressants is permitted if this medication is not changed within a period of 6 weeks prior to participation in the study. Additionally, no changes in antidepressant medication are allowed during active participation in the study.
- •Chronic depression (> two years duration).
- •Dysthymia as a primary axis-1 diagnosis
- •Bipolar disorder or schizophrenia as a primary axis-1 diagnosis
- •Severe suicidality (HDRS item # 3 with a score >2) or severe depression symptomatology (HDRS score > 25).
- •Pregnancy.
- •Age < 18 years.
- •Daily alcoholintake of >7 units.
研究者
相似试验
尚未招募
1 期
A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19)ITMCTR2000003033Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,
已完成
不适用
Study on the effectiveness paracetamol two hours before Electro Convulsive Therapy (ECT) to reduce the incidence and severity of post ECT headache.Post ECT headacheSLCTR/2015/027Professorial Psychiatry Unit,
已完成
3 期
The randomized controlled trial of the efficacy of goshajinkigan, mecobalamin and lafutidine in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010969Department of breast and endocrine surgery, Meiwa Hospital50
已完成
3 期
The randomized controlled trial of the efficacy of goshajinkigan and lafutidine after mecobalamin administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010988Department of breast and endocrine surgery, Meiwa Hospital35
已完成
3 期
The randomized controlled trial of the efficacy of mecobalamin and lafutidine after goshajinkigan administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000011007Department of breast and endocrine surgery, Meiwa Hospital35